Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing delafloxacin to ceftriaxone for uncomplicated gonorrhea was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Delafloxacin (delafloxacin)
  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Gonorrhea | Phase 3 | Status: TERMINATED | Results posted: 2018-04-26